Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis

Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication...

Full description

Saved in:
Bibliographic Details
Published in:The Brazilian journal of infectious diseases 2008-08, Vol.12 (4), p.263-263
Main Authors: Tuon, Felipe Francisco, Guastini, Cristina Maria de Fátima, Boulos, Maria Ivete Castro
Format: Article
Language:English
Subjects:
Acute Disease
amylases
chronic B hepatitis
Complications and side effects
Dosage and administration
Drug therapy
hepatitis
Hepatitis B
Hepatitis B, Chronic - drug therapy
Humans
hyperamilasemina
Hyperamylasemia - chemically induced
INFECTIOUS DISEASES
Lamivudine
Lamivudine - adverse effects
Lamivudine - therapeutic use
Male
Middle Aged
Pancreatitis
Pancreatitis - chemically induced
Pancreatitis - enzymology
Reverse Transcriptase Inhibitors - adverse effects
Reverse Transcriptase Inhibitors - therapeutic use
Risk factors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.
ISSN:1413-8670
1678-4391
1678-4391
DOI:10.1590/S1413-86702008000400001